The closer the match between the circulating strains causing disease and the strains in the vaccine, the better
the protection against influenza.
Protection against influenza and viruses.
Correlates of
Protection against Influenza in the Elderly: Results from an Influenza Vaccine Efficacy Trial.
Balazs AB, Bloom JD, Hong CM, Rao DS, Baltimore D. Broad
protection against influenza infection by vectored immunoprophylaxis in mice.
In the new analysis, investigators sought to understand the role of pre-existing anti-HA stem antibodies in
protection against influenza using data from a healthy volunteer influenza challenge trial that took place in 2013 at the NIH Clinical Center in Bethesda, Maryland.
Higher levels of HA antibodies in a person's body have long been associated with greater
protection against influenza infection.
It's possible that getting sick with one type of influenza A virus would offer some modest protection against another type of influenza A, but it probably wouldn't give
you any protection against the influenza B virus, Schaffner said.
Not exact matches
National
Influenza Vaccination Week — December 7th — 13th The Oneida County Health Department reminds everyone that the best
protection against the flu is the flu vaccine and encourages everyone 6 - months and older who has not yet received a flu shot to do so during National
Influenza Immunization Week — December 7th — 13th.
These included the past two flu seasons in which vaccines offered only limited
protection against the most widely circulating strain of
influenza A.
Scientists may be able to create a «universal» vaccine that can provide broad
protection against numerous
influenza strains, including those that could cause future pandemics.
These antibodies protect
against certain strains of
influenza virus in the vaccine, but may not provide thorough
protection against other strains of flu that may be present.
«This new synthetic DNA - based strategy — termed DMAb's — delivers monoclonal antibodies that provide
protection against highly diverse strains of
influenza.»
«Although this is preclinical work, the strategy warrants further investigation because it holds promise as a simple, economical way to overcome the major limitation of current flu vaccination strategies and may provide broad
protection against seasonal and pandemic
influenza,» added Elliott.
Researchers concluded that the high - dose vaccine is safe, induces significantly higher antibody responses, and provides superior
protection against laboratory - confirmed
influenza illness compared to standard dose among persons over 65 years of age.
But «the breadth of
protection against numerous
influenza strains was not investigated here,» and will be important work for the future, he says.
When the researchers exposed chickens to lethal doses of the avian
influenza virus and the Newcastle virus, birds inoculated with the recombinant vaccine produced antibodies
against both viruses, offering
protection against both diseases.
1009 - 3B06 and 70 - 1F02 showed
protection against these antigenically distinct H1N1
influenza strains, as illustrated in Fig. 5.
Their results, the researchers conclude, «show that computationally designed proteins have potent anti-viral efficacy in vivo and suggests promise for development of a new class of HA stem - targeted antivirals for both therapeutic and prophylactic
protection against seasonal and emerging strains of
influenza.»
Protection of mice
against lethal challenge with 2009 H1N1
influenza A virus by 1918 - like and classical swine H1N1 based vaccines
Influenza vaccines that better target the influenza surface protein called neuraminidase (NA) could offer broad protection against various influenza virus strains and less
Influenza vaccines that better target the
influenza surface protein called neuraminidase (NA) could offer broad protection against various influenza virus strains and less
influenza surface protein called neuraminidase (NA) could offer broad
protection against various
influenza virus strains and less
influenza virus strains and lessen the...
«
Influenza yearly
protection is important for preventing the flu,» said Spicehandler, who is co-chief of infectious diseases at Northern Westchester Hospital in Mount Kisco, N.Y. «Each year the vaccine is made up of different strains to protect
against what viruses are prevalent.»
Introducing VANGUARD ® CIV H3N2 / H3N8, a bivalent canine flu vaccine with demonstrated safety and efficacy for
protection against both highly contagious H3N2 and H3N8 strains of canine
influenza virus (CIV).
Protection against canine
influenza is expected to last for 1 year.
Discuss additional risk - based vaccination needs annually with your veterinarian for
protection against equine
influenza, equine herpesvirus, strangles, leptospirosis and more.
Non-structural protein 1 (NS1) truncated (NS1 - 126, NS1 - 99 and NS1 - 73) or deleted (DNS1) H3N8 canine
influenza viruses (CIVs) were tested for their safety, immunogenicity and
protection efficacy as live - attenuated
influenza vaccines (LAIVs)
against wild - type (WT) H3N8 CIV.
«Zoetis offers a complete line of vaccines for
protection from common equine diseases, including WEST NILE - INNOVATOR ®, to help protect
against West Nile virus, and FLUVAC INNOVATOR, to help protect
against equine
influenza virus and EHV - 1 and EHV - 4.
We have the newly released vaccine that provides
protection against both the H3N8 and H3N2 Canine
Influenza strains that we are seeing in the reported cases.
H3N2 (flu)-- This vaccine contains
protection against H3N2 canine
influenza.
«Our new bivalent canine
influenza vaccine will simplify
protection against this disease and is a tremendous example of our ongoing pursuit of the science of healthier animals and our dedication to providing veterinarians with new medicines and vaccines to advance optimal pet care.»
Fluvac Innovator ® vaccines are the most trusted equine
influenza vaccines and help provide your horse with broad
protection against newly emerging and conventional equine
influenza virus strains as well as equine herpesvirus (EHV 1 and EHV 4).4 - 10 Zoetis regularly tests Fluvac Innovator to ensure its vaccine continues to be effective
against emerging EIV isolates.
In addition to helping deliver
protection against equine
influenza due to Type A2 viruses, FLUVAC INNOVATOR 6 aids in the prevention of equine rhinopneumonitis due to EHV - 1 and EHV - 4; equine encephalomyelitis due to Eastern, Western and Venezuelan encephalomyelitis viruses; and tetanus.